Triethylamine → HCID 44256300, compound
Reaction equation
[Cl:1][C:2]1[CH:29]=[CH:28][C:5]2[N:6]=[C:7]([NH:9][C:10]3[CH:15]=[CH:14][C:13]([C:16]4[N:20]5[CH:21]=[CH:22]C=[C:24]([C:25](O)=[O:26])[C:19]5=[N:18][N:17]=4)=[CH:12][CH:11]=3)[S:8][C:4]=2[CH:3]=1.C1C=CC2N(O)N=[N:36]C=2C=1.Cl.[NH2:41][C@@H:42]([CH2:45][CH3:46])[CH2:43][OH:44].C(N(CC)CC)C>CN(C=O)C.C(Cl)CCl.C(Cl)Cl>[Cl:1][C:2]1[CH:29]=[CH:28][C:5]2[N:6]=[C:7]([NH:9][C:10]3[CH:15]=[CH:14][C:13]([C:16]4[N:20]5[CH:21]=[CH:22][N:36]=[C:24]([C:25]([NH:41][C@@H:42]([CH2:45][CH3:46])[CH2:43][OH:44])=[O:26])[C:19]5=[N:18][N:17]=4)=[CH:12][CH:11]=3)[S:8][C:4]=2[CH:3]=1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 3
Procedure
A suspension of 3-(4-(6-chlorobenzo[d]thiazol-2-ylamino)phenyl)-[1,2,4]triazolo[4,3-a]pyridine-8-carboxylic acid (63E) (43 mg, 0.1 mmol), EDC (24.4 mg, 0.127 mmol) and HOBt (17.2 mg, 0.127 mmol) in DMF (1 mL) was stirred for 5 min, and then (S)-2-aminobutan-1-ol, hydrochloride salt (13 mg, 0.104 mmol) and triethylamine (20.6 mg, 0.203 mmol) were added. The mixture was stirred at room temperature overnight. To the reaction mixture was added anhydrous DCM (1 mL), followed by additional EDC (25 mg) and HOBt (17 mg). The resulting mixture was then stirred for additional 2 h before concentrated in vacuo. The crude product was purified by preparative HPLC using MeOH/H2O/TFA solvent system to yield the title compound (3 mg). HPLC/MS (Method C): retention time=2.14 min (broad rotomer), [M+H]+=494.1. 1H NMR (500 MHz, DMSO-d6): δ 10.97 (s, 1H), 8.98 (d, J=8.25 Hz, 1H), 8.77 (d, J=4.95 Hz, 1H), 8.02-8.09 (m, 3H), 7.93-8.01 (m, 3H), 7.64 (d, J=8.80 Hz, 1H), 7.38 (dd, J=8.80, 2.20 Hz, 1H), 3.94-4.03 (m, 1H), 3.57 (dd, J=10.72, 4.67 Hz, 1H), 3.48 (dd, J=11.00, 5.50 Hz, 1H), 1.48-1.61 (m, 1H). 0.89-1.02 (m, 3H).
Workup
- stirringThe mixture was stirred at room temperature overnight
- stirringThe resulting mixture was then stirred for additional 2 h
- concentrationbefore concentrated in vacuo
- customThe crude product was purified by preparative HPLC
Sources & evidence
- ORD record
- ord-963066769b014e2c8e27bb14c51cfca7
- Source dataset
- uspto-grants-2012_12
- Patent number
- US08324241B2
Reaction notes
Loading…